ALLIED HEALTHCARE PRODUCTS INC

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2023-03-31

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2022-12-31

Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending 2022-09-30

Annual Report for period ending 2022-06-30

Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending 2022-06-30

Quarterly Report for period ending 2022-03-31

Quarterly Report for period ending 2021-12-31

Quarterly Report for period ending 2021-09-30

Annual Report for period ending 2021-06-30

Quarterly Report for period ending 2021-03-31

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

Annual report to security holders

Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

Annual report to security holders

WEIL JOHN D: Major Shareholders

WEIL JOHN D: Statement of changes in beneficial ownership of securities

WEIL JOHN D: Major Shareholders

Root Joseph Ernest JR: Statement of changes in beneficial ownership of securities

WEIL JOHN D: Statement of changes in beneficial ownership of securities

GRAVES JUDY T: Statement of changes in beneficial ownership of securities

Deuser Susan M: Statement of changes in beneficial ownership of securities

WEIL JOHN D: Major Shareholders

Kroupa Kevin D: Initial statement of beneficial ownership of securities

REFSLAND EARL R: Statement of changes in beneficial ownership of securities

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Definitive proxy statements

Definitive proxy statements

Definitive proxy statements

Definitive proxy statements

Definitive proxy statements

Definitive proxy statements

Definitive proxy statements

Preliminary proxy statement not related to a contested matter or merger/acquisition

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.